Samuel George A. Iii - Net Worth and Insider Trading

Samuel George A. Iii Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samuel George A. Iii owns 1 companies in total, including Lineage Cell Therapeutics Inc (LCTX) .

Click here to see the complete history of Samuel George A. Iii’s form 4 insider trades.

Insider Ownership Summary of Samuel George A. Iii

Ticker Comapny Transaction Date Type of Owner
LCTX Lineage Cell Therapeutics Inc 2021-09-01 General Counsel/Secretary

Samuel George A. Iii Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Samuel George A. Iii Ownership Network

Ownership Network List of Samuel George A. Iii

No Data

Ownership Network Relation of Samuel George A. Iii


Samuel George A. Iii Owned Company Details

What does Lineage Cell Therapeutics Inc do?

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cell transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Who are the key executives at Lineage Cell Therapeutics Inc?

Samuel George A. Iii is the General Counsel/Secretary of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include Chief Financial Officer Jill Ann Howe , Chief Financial Officer Kevin Leon Cook , and Sr Director Finance/Controller Alexandra Hernandez .

Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary

Over the past 18 months, Samuel George A. Iii made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 930,106 shares made by Broadwood Partners Lp , a net sale of 539,283 shares made by Gary S. Hogge , and a net purchase of 35,000 shares made by Dipti Amin .

In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 539,283 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 977,356 shares were bought by its insiders, resulting in a net purchase of 438,073 shares.

Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AMEX:LCTX Insider Transactions

20/Page
Total 0
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

Samuel George A. Iii Mailing Address

Above is the net worth, insider trading, and ownership report for Samuel George A. Iii. You might contact Samuel George A. Iii via mailing address: C/o Lineage Cell Therapeutics, Inc., 2173 Salk Avenue, Suite 200, Carlsbad Ca 92008.